Abstract GS1-06: Circulating tumor DNA (ctDNA) in human epidermal growth factor receptor 2-positive (HER2[+]) Early Breast Cancer (EBC): Translational analysis of PHERGain neoadjuvant tailored treatment study
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: A. Llombart-Cussac, J. Pérez-García, M. Ruiz-Borrego, A. Stradella, B. Bermejo, S. Escrivá-de-Romaní, C. Reboredo, N. Ribelles, A. Cortés-Salgado, C. Albacar, M. Colleoni, G. Antonarelli, G. Notini, M. Gion, J. García-Mosquera, L. Sanz, E. Martínez-García, P. González-Alonso, A. Amaya-Garrido, J. Guerrero, J. Rodríguez-Morató, L. Mina, G. Martrat, M. Quintana, F. Riva, D. Dustin, H. Zhang, M. Mancino, J. Cortés
Institutions: Universidad Cardenal Herrera CEU, MedSIR (Spain), Hospital Arnau de Vilanova, Hospital Universitario Virgen del Rocío, Institut Català d'Oncologia, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, Centro de Investigación Biomédica en Red de Cáncer, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Complexo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Ramón y Cajal, Institut de Recerca Biomèdica Catalunya Sud, Hospital Universitari Sant Joan de Reus, European Institute of Oncology, University of Milan, Hospital Universitario Dexeus, Guardant (United States), Hospital Universitario de Torrejón, Universidad Europea de Madrid
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129574761